JFS Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
JFS Wealth Advisors's BIIB Position: Q2 2026 in Review
JFS Wealth Advisors increased its Biogen (BIIB) stake by 8.8% in Q2 2026, buying an estimated $1.15K and bringing the position to 74 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #830.
JFS Wealth Advisors first reported a position in BIIB in Q4 2014 and has held it in 20 quarters since. The position peaked at $25.5K in Q4 2022. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- JFS Wealth Advisors held 74 shares of Biogen worth $16K as of Q2 2026.
- JFS Wealth Advisors bought 6 Biogen shares in Q2 2026, an estimated $1.15K.
- Biogen made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #830 holding.
- JFS Wealth Advisors first reported a position in Biogen in Q4 2014 and has held it in 20 quarters since.
- JFS Wealth Advisors's Biogen position peaked at $25.5K in Q4 2022.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.